Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Supratentorial grade II astrocytoma: biological features and clinical course.

The Lancet. Neurology - 1 Jul 2003

Wessels Peter H, Weber Wim E J, Raven Guy, Ramaekers Frans C S, Hopman Anton H N, Twijnstra Albert

Abstract excerpt

Because of its unpredictable clinical course, treatment strategies for low-grade (grade II) astrocytoma vary from "wait and see" to gross tumour resection followed by immediate radiotherapy. Clinical studies on grade II astrocytoma show that 5-year-survival ranges from 27% to 85% of patients with very few consistent prognostic variables besides the patient's age and the presence of neurological deficit. There is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Treatment Outcome
Share to Age Factors
Share to Astrocytoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Transformation, Neoplastic

Share to Disease Progression

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 12849117
DOI: 10.1016/s1474-4422(03)00434-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Supratentorial grade II astrocytoma: biological features and clinical course.PMID 12849117Read ↗

Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.Semantic proximity Read ↗

Astrocytic gliomas WHO grades II and III.Semantic proximity Read ↗

Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.Semantic proximity Read ↗

IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.Semantic proximity Read ↗

Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2-wildtype astrocytomas.Semantic proximity Read ↗

Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas.Semantic proximity Read ↗

Molecular pathogenesis of astrocytic tumours.Semantic proximity Read ↗

Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis.Semantic proximity Read ↗

Importance of GFAP isoform‐specific analyses in astrocytomaSemantic proximity Read ↗

A Molecular Genetic Model of Astrocytoma HistopathologySemantic proximity Read ↗

Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.Semantic proximity Read ↗

Impact of morphology and biology on the prognosis of patients with gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.